Knowledge @lert for Wednesday 8th July

July 8, 2015 Daily News

Plan to combine regulators and safety in single ‘new body’ – Health Service Journal
Many of the functions of Monitor and the NHS Trust Development Authority are expected to be brought together in a single ‘new body’, which would also take on new patient safety and improvement work.

Contact the Library & Knowledge Service to request this article in full or Phn. 01704 704202

NHS England ‘didn’t like answer’ on safe staffing – Health Service Journal
A senior figure at the National Institute for Health and Care Excellence has suggested NHS England scrapped its work on safe staffing guidance because it ‘didn’t like the answer to the question’.

Contact the Library & Knowledge Service to request this article in full or Phn. 01704 704202

Social enterprise publishes clinical data via online database – Health Service Journal
A social enterprise which provides community services across south London has published anonymised clinical data onto a website created by the Greater London Authority to aid public scrutiny of the way services are run. Bromley Healthcare is the first provider of NHS services to upload data on appointments and patient outcomes to theLondon Datastore, which enables people to freely access various datasets about the city.

Contact the Library & Knowledge Service to request this article in full or Phn. 01704 704202

Measuring and improving patients’ experience of care: report of a summit for pharmacy teams – Royal Pharmaceutical Society (RPS)
In April 2015, RPS held a one day summit focusing on how pharmacy teams could measure and improve patients’ experience of care. This event brought together experts with insight and experience of how to both raise the profile of patient experience in organisations, and how to measure and evaluate it in practice, with local NHS teams sharing their individual approaches. This report summarises the discussions of the day and can be used as a resource to support the continued development of pharmacy approaches to evaluating and improving patients’ experience of care.

Better value in the NHS
The Kings Fund has published Better value in the NHS – report summary. This summary report calls on doctors, nurses and other staff to deliver better outcomes at lower costs. It provides examples where potential savings could still be made resulting in better outcomes and concludes that the challenge facing the NHS over the coming years is fundamentally about improving value rather than reducing costs. The full report will be available in due course.

Health policy priorities for a new parliament
The Kings Fund has published Health policy priorities for a new parliament. This report is a collection of essays, published jointly by the All-Party Parliamentary Health Group and The King’s Fund, which maps out health priorities for the next parliament, as seen from the perspective of key stakeholders in the world of health.

Health and wellbeing of NHS staff
NHS Employers has published Global Corporate Challenge – a health and wellbeing initiative with a difference. This case study shows how Chesterfield Royal Hospital NHS Foundation Trust signed up to the Global Corporate Challenge and encouraged staff to take part in an initiative to raise awareness of their health and wellbeing. This case study details the steps taken to deliver the initiative, the resources needed, key challenges and top tips for other trusts looking to take on the Global Corporate Challenge.

Mental health key facts app
The Royal College of Psychiatrists has launched a new app giving access to the College’s mental health information leaflets, videos and podcasts. RCPsych Key Facts App is available from iTunes and Android Play Store.

Evidence summary: new medicines – Type 2 diabetes: insulin degludec/liraglutide (Xultophy)
NICE has published a new medicines evidence summary, Type 2 diabetes: insulin degludec/liraglutide (Xultophy) (ESNM60). Evidence summaries: new medicines’ provide a summary of the published evidence for selected new medicines, or for existing medicines with new indications or formulations, that are considered to be of significance to the NHS. The strengths and weaknesses of the relevant evidence are critically reviewed within the summary, but the summaries are not formal NICE guidance.

Bulletins